PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
05-Jul-2024 HUTCHMED Announces NDA Acceptance in China for Tazemetostat for the Treatment of Relapsed or Refractory Follicular Lymphoma with Priority Review Status HUTCHMED
05-Jul-2024 Researchers map the effects of all potential changes in key cancer gene Francis Crick Institute
05-Jul-2024 HUTCHMED Announces NDA Acceptance in China for Tazemetostat for the Treatment of Relapsed or Refractory Follicular Lymphoma with Priority Review Status HUTCHMED
05-Jul-2024 Anacura acquires OHMX.bio, adding multi-omics for drug discovery and diagnostics to its services. Anacura
03-Jul-2024 Pneumagen Highlights Broad-Spectrum Antiviral Activity of First-in-Class Intranasal Drug Neumifil in New Publication Pneumagen
03-Jul-2024 Syncona portfolio company Beacon Therapeutics raises $170 million in a Series B financing Syncona Limited
02-Jul-2024 Almirall launches Act4Impact – its updated sustainability strategy setting ambitious targets for 2030 Almirall
02-Jul-2024 Sobi initiates rolling biologics license application to FDA for SEL-212 for the potential treatment of chronic refractory gout Sob
02-Jul-2024 Mission Therapeutics awarded $5.2m from The Michael J. Fox Foundation and Parkinson’s UK to advance potential disease-modifying treatment MTX325 Mission Therapeutics
02-Jul-2024 ramarketing strengthens AI capabilities with key leadership appointments ramarketing
02-Jul-2024 Clinigen appoints Fernando Ballester as Chief Financial Officer Clinigen
01-Jul-2024 Biora Therapeutics Announces Positive Clinical Trial Results for BT-600 Biora Therapeutics
28-Jun-2024 Almirall’s Ilumetri® (tildrakizumab) restores and maintains wellbeing of patients with moderate-to-severe plaque psoriasis to the levels of the general population for up to 1 year[i] Almirall
25-Jun-2024 Proscia And Nucleai Partner To Broaden Access To AI Predictive Biomarkers Proscia
25-Jun-2024 Emmes partners with ILiAD Biotechnologies to Conduct Phase III Clinical Trials of BPZE1, the Leading Next-Generation Pertussis Vaccine ILiAD Biotechnologies, LLC
25-Jun-2024 HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda HUTCHMED
20-Jun-2024 New Phesi proof of concept demonstrates potential of AI-powered digital twins to replace external control arms in clinical trials Bone Marrow Transplantation (BMT-Nature).
20-Jun-2024 iOnctura announces EUR80 million Series B financing to progress pipeline through Phase II trials iOnctura
20-Jun-2024 Clinion and Clinevo’s Strategic Alliance for An Integrated eClinical Experience Clinion Inc
19-Jun-2024 European Commission grants Sobi® Marketing Authorisation for ALTUVOCT™ for treatment of haemophilia A European Commission